Clinical Trials in Arizona

Showing 4001-4020 of 16,770 trials

Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer

NCT04669197

To evaluate the normalization rate of CA 19-9 of individuals with non-metastatic pancreas cancer following up to 6 months of neoadjuvant chemotherapy.

Untreated Resectable Pancreatic AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma

HonorHealth Research Institute19 participantsStarted Dec 2020

Scottsdale, Arizona, United States

COMPLETEDPhase 235 miles

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

NCT02924376

The purpose of this study is evaluate the efficacy of pemigatinib in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.

Cholangiocarcinoma

Incyte Corporation147 participantsStarted Jan 2017

Anchorage, Alaska, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +117 more locations

Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Find Trials by Condition in Arizona

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Lupus Landmark Study: A Prospective Registry and Biorepository

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Actis Total Hip System 2 Year Follow-up

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours